Impaired glucose metabolism moderates the course of illness in bipolar disorder-Reference-Cited by-同舟云学术

Impaired glucose metabolism moderates the course of illness in bipolar disorder

Published:2016-05 Issue: Volume:195 Page:57-62
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Mansur Rodrigo B.,Rizzo Lucas B.,Santos Camila M.,Asevedo Elson,Cunha Graccielle R.,Noto Mariane N.,Pedrini Mariana,Zeni Maiara,Cordeiro Quirino,McIntyre Roger S.,Brietzke Elisa

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference54 articles.

1. Standards of medical care in diabetes--2014;Association;Diabetes Care,2014

2. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes;Baker;Arch. Neurol.,2011

3. Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients;Baldessarini;J. Affect. Disord.,2012

4. Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders;Birmaher;Am J. Psychiatry,2014

5. Insulin dysfunction and allostatic load in bipolar disorder;Brietzke;Expert Rev. Neurother.,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of Circulating Biomarkers with Disease Risks: A Two-Sample Mendelian Randomization Study;International Journal of Molecular Sciences;2024-07-05

2. Associations of Circulating Biomarkers with Disease Risks: a Two-Sample Mendelian Randomization Study;2024-07-01

3. Prevalence of insulin resistance and its associated factors in drug-naïve patients with bipolar disorder among Han Chinese population;BMC Psychiatry;2024-05-23

4. Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial;Psychiatry Research;2024-05

5. Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders;International Clinical Psychopharmacology;2023-10-21